Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
nm21-1480 (1 trial)
nm26-2198 (1 trial)
Neoplasms (Phase 2)
Trials (2 total)
Trial APIs (2 total)